Skincare interventions in infants for preventing eczema and food allergy

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 2, 2020, Pages

  Kelleher, Maeve M ^a   Cro, Suzie ^b   Cornelius, Victoria ^b   Axon, Emma ^c   Lodrup Carlsen, Karin C ^d,e   Skjerven, Håvard Ove ^d   Rehbinder, Eva Maria ^d,e   Lowe, Adrian ^f   Dissanayake, Eishika ^g   Shimojo, Naoki ^h   Yonezawa, Kaori ⁱ   Ohya, Yukihiro ^j   Yamamoto Hanada, Kiwako ^j   Morita, Kumiko ^k   Surber, Christian ^l,m   Cork, Michael ⁿ   Cooke, Alison ^o   Tran, Lien ^b   Askie, Lisa M ^p   Duley, Lelia ^q   Chalmers, Joanne R ^c   Williams, Hywel C ^c   Boyle, Robert J ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h CHIBA UNIVERSITY   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^k KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^m UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁿ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^o UNIVERSITY OF MANCHESTER   (United Kingdom)

^p UNIVERSITY OF SYDNEY   (Australia)

^q QUEEN S MEDICAL CENTRE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT;

AGE; ARTICLE; DATA ANALYSIS; DATA EXTRACTION; ECZEMA; FOOD ALLERGY; HUMAN; INFANCY; INFANT; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RISK BENEFIT ANALYSIS; SKIN CARE; SYSTEMATIC REVIEW;

EID: 85079491840     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD013534     Document Type: Article

References (117)

1. Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 2018;73(3):696-704.
2. ACTRN12613000472774. The PEBBLES study: prevention of eczema by a barrier lipid equilibrium strategy [Does twice daily application of a ceramide dominant cream (EpiCeram) for the first six months of life reduce the incidence of eczema by six months of age, when compared to standard skin care, in infants who have a family history of allergic disease]. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364115 (first received 26 April 2013).
3. Amare Y, Shamba DD, Manzi F, Bee MH, Omotara BA, Iganus RB, et al. Current neonatal skin care practices in four African sites. Journal of Tropical Pediatrics 2015;61(6):428-34. [DOI: 10.1093/tropej/fmv053]
4. Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. Journal of Clinical Epidemiology 2013;66(7):726-35. [DOI: 10.1016/j.jclinepi.2013.02.003]
5. Apfelbacher CJ, Diepgen TL, Schmitt J. Determinants of eczema: population-based cross-sectional study in Germany. Allergy 2011;66(2):206-13.
6. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368(9537):733-43.
7. Bai G, Herten MH, Landgraf JM, Korfage IJ, Raat H. Childhood chronic conditions and health-related quality of life: findings from a large population-based study. PloS one 2017;12(6):e0178539.
8. Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy 2018;73(6):1284-93.
9. Blume-Peytavi U, Cork M, Faergemann J, Szczapa J, Vanaclocha F, Gelmetti C. Bathing and cleansing in newborns from day 1 to first year of life: recommendations from a European round table meeting. Journal of the European Academy of Dermatology and Venereology 2009;23(7):751-9.
10. Blume-Peytavi U, Lavender T, Jenerowicz D, Ryumina I, Stalder JF, Torrelo A, et al. Recommendations from a European roundtable meeting on best practice healthy infant skin care. Pediatric Dermatology 2016;33(3):311-21.
11. Bock SA, Sampson HA, Atkins FM, Zeiger RS, Lehrer S, Sachs M, et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. Journal of Allergy and Clinical Immunology 1988;82(6):986-97.
12. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. Journal of Allergy and Clinical Immunology 2010;126(6):S1-58.
13. Boyle R, Williams H, Askie L, Lodrup-Carlsen K, Montgomery A, Chalmers J, et al. Prospectively planned meta-analysis of skin barrier studies for the prevention of eczema and associated health conditions. www.crd.york.ac.uk/prospero/display_record.php?RecordID=56965 (first received 10 February 2017).
14. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatric Dermatology 2005;22(3):192-9.
15. Caussin J, Rozema E, Gooris GS, Wiechers JW, Pavel S, Bouwstra JA. Hydrophilic and lipophilic moisturizers have similar penetration profiles but different effects on SC water distribution in vivo. Experimental Dermatology 2009;18(11):954-61.
16. Chalmers JR, Haines RH, Mitchell EJ, Thomas KS, Brown SJ, Ridd M, et al. Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (the BEEP trial): protocol for a randomised controlled trial. Trials 2017;18(1):343.
17. Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Archives of Dermatology 2004;140(12):1513-9.
18. Cook JA, MacLennan GS, Palmer T, Lois N, Emsley R. Instrumental variable methods for a binary outcome were used to informatively address noncompliance in a randomized trial in surgery. Journal of Clinical Epidemiology 2018;96:126-32.
19. Cooke A, Bedwell C, Campbell M, McGowan L, Ersser SJ, Lavender T. Skin care for healthy babies at term: a systematic review of the evidence. Midwifery 2018;56:29-43.
20. Cork MJ, Murphy R, Carr J, Buttle D, Ward S, Båvik C, et al. The rising prevalence of atopic eczema and environmental trauma to the skin. Dermatology in Practice 2002;10(3):22-6.
21. Cro S, Boyle R, Kelleher M, Tran L, Cornelius V. Skin care interventions for preventing eczema and food allergy: a statistical analysis plan for a systematic review and individual participant data meta-analysis. zenodo.org/record/3610604#.XiGKU8j7SUk (accessed 16 January 2020). [DOI: 10.5281/zenodo.3610604]
22. Danby SG, Al-Enezi T, Sultan A, Chittock J, Kennedy K, Cork MJ. The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis. British Journal of Dermatology 2011;165(2):329-34.
23. Danby SG, Brown K, Wigley AM, Chittock J, Pyae PK, Flohr C, et al. The effect of water hardness on surfactant deposition after washing and subsequent skin irritation in atopic dermatitis patients and healthy control subjects. Journal of Investigative Dermatology 2018;138(1):68-77.
24. Deckers IA, McLean S, Linssen S, Mommers M, Van Schayck CP, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990–2010: a systematic review of epidemiological studies. PloS One 2012;7(7):e39803.
25. Deeks JJ, Higgins JP, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
27. Drucker AM, Wang AR, Li W-Q, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. Journal of Investigative Dermatology 2017;137(1):26-30.
28. Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. New England Journal of Medicine 2015;372(9):803-13.
29. du Toit G, Tsakok T, Lack S, Lack G. Prevention of food allergy. Journal of Allergy and Clinical Immunology 2016;137(4):998-1010.
30. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
31. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: Part 2: Management and treatment of atopic dermatitis with topical therapies. Journal of the American Academy of Dermatology 2014;71(1):116-32.
32. Engebretsen KA, Bager P, Wohlfahrt J, Skov L, Zachariae C, Nybo Andersen AM, et al. Prevalence of atopic dermatitis in infants by domestic water hardness and season of birth: cohort study. Journal of Allergy and Clinical Immunology 2017;139(5):1568-1574.e1.
33. Ewence A, Rumsby P, Danby S, Cork MJ, Williams HC. A review of skin irritation and tap water. www.dwi.defra.gov.uk/research/completed-research/reports/dwi70-2-257.pdf. Wrc. Swindon. UK, accessed prior to 24 January 2019; Vol. DWI8375.01.
34. Flohr C, England K, Radulovic S, McLean WH, Campbell LE, Barker J, et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. British Journal of Dermatology 2010;163(6):1333-6.
35. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014;69(1):3-16.
36. Furlan AD, Pennick V, Bombardier C, Van Tulder M, Editorial Board, Cochrane Back Review Group. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009;34(18):1929-41.
37. Garcia Bartels N, Mleczko A, Schink T, Proquitté H, Wauer RR, Blume-Peytavi U. Influence of bathing or washing on skin barrier function in newborns during the first four weeks of life. Skin Pharmacology and Physiology 2009;22(5):248-57.
38. Garcia Bartels N, Scheufele R, Prosch F, Schink T, Proquitté H, Wauer RR, et al. Effect of standardized skin care regimens on neonatal skin barrier function in different body areas. Pediatric Dermatology 2010;27(1):1-8.
39. Ghersi D, Berlin J, Askie L. Chapter 19: Prospective meta-analysis. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
40. Grabenhenrich LB, Reich A, Bellach J, Trendelenburg V, Sprikkelman AB, Roberts G, et al. A new framework for the documentation and interpretation of oral food challenges in population-based and clinical research. Allergy 2017;72(3):453-61.
41. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clinical & Experimental Allergy 2004;34(4):520-6.
42. Gupta R, Holdford D, Bilaver L, Dyer A, Holl JL, Meltzer D. The economic impact of childhood food allergy in the United States. JAMA Pediatrics 2013;167(11):1026-31.
43. Gupta RS, Warren CM, Smith BM, Jiang J, Blumenstock JA, Davis MM, et al. Prevalence and severity of food allergies among US adults. JAMA Network Open 2019;2(1):e185630.
44. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermato-Venereologica 1980;60 Suppl 92:44-7.
45. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Experimental Dermatology 2001;10(1):11-8.
46. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443-57.
47. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
48. Higgins JP, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
49. Higgins JP, Savovic J, Page MJ, Sterne JA, ROB2 development group. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/current-version-of-rob-2 (accessed 5 February 2019).
50. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
51. Horimukai K, Morita K, Narita M, Kondo M, Kitazawa H, Nozaki M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. Journal of Allergy and Clinical Immunology 2014;134(4):824-830.e6.
52. Irvin EJ, Miller HD. Emollient use in the term newborn: a literature review. Neonatal Network: NN 2015;34(4):227-30.
53. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. New England Journal of Medicine 2011;365(14):1315-27.
54. ISRCTN 21528841. Barrier enhancement for eczema prevention. www.isrctn.com/ISRCTN21528841 (first received 25 July 2014).
55. Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations. Journal of Allergy and Clinical Immunology 2014;134(6):1318-28 e7.
56. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization. Journal of Allergy and Clinical Immunology 2003;113(5):832-6.
57. JPRN-UMIN000004544. Effect of emollients on the prevention of infantile eczema and atopic dermatitis. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005429 (first received 11 November 2010).
58. JPRN-UMIN000010838. Skin care and synbiotics for prevention of atopic dermatitis or food allergy in newborn infants: a 2 x 2 factorial, randomized, non-treatment controlled trial. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012665 (first received 30 May 2013).
59. JPRN-UMIN000013260. Effects of moisturizing skin care from the neonatal stage for improving skin barrier function and preventing skin trouble. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014285 (first received 25 February 2014).
60. Kelleher MM, Dunn-Galvin A, Gray C, Murray DM, Kiely M, Kenny L, et al. Skin barrier impairment at birth predicts food allergy at 2 years of age. Journal of Allergy and Clinical Immunology 2016;137(4):1111-1116.e8.
61. Cummings AJ, Knibb RC, King RM, Lucas JS. The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 2010;65:933-45.
62. Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, Noel-Storr A, Rader T, Shokraneh F, Thomas J, Wieland LS. Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 6. Cochrane, 2019. Available from www.training.cochrane.org/handbook.
63. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. Journal of Clinical Investigation 2004;113(5):651-7.
64. Lodén M. Effect of moisturizers on epidermal barrier function. Clinics in Dermatology 2012;30(3):286-96.
65. Lowe AJ, Su JC, Allen KJ, Abramson MJ, Cranswick N, Robertson CF, et al. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study. British Journal of Dermatology 2018;178(1):e19-21.
66. Luoma R, Koivikko A, Viander M. Development of asthma, allergic rhinitis and atopic dermatitis by the age of five years. A prospective study of 543 newborns. Allergy 1983;38(5):339-46.
67. Lødrup Carlsen KC, Rehbinder EM, Skjerven HO, Carlsen MH, Fatnes TA, Fugelli P, et al. Preventing atopic dermatitis and allergies in children—the PreventADALL study. Allergy 2018;73(10):2063-70.
68. Mancini A, Lawley L. Structure and function of newborn skin. Neonatal Dermatology. 2nd Edition. Philadelphia: Elsevier Saunders, 2008:19-31.
69. Martin PE, Koplin JJ, Eckert JK, Lowe AJ, Ponsonby AL, Osborne NJ, et al. The prevalence and socio-demographic risk factors of clinical eczema in infancy: a population-based observational study. Clinical and Experimental Allergy 2013;43(6):642-51.
70. Martin PE, Eckert JK, Koplin JJ, Lowe AJ, Gurrin LC, Dharmage SC, et al. Which infants with eczema are at risk of food allergy? Results from a population-based cohort. Clinical and Experimental Allergy 2015;45(1):255-64.
71. McAleer MA, Jakasa I, Raj N, O'Donnell CP, Lane ME, Rawlings AV, et al. Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis. British Journal of Dermatology 2018;179(2):431-41.
72. Meckfessel MH, Brandt S. The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products. Journal of the American Academy of Dermatology 2014;71(1):177-84.
73. NCT01375205. Comparing cetaphil restoraderm system versus standard skin care in infants. clinicaltrials.gov/ct2/show/results/NCT01375205 (first received 17 June 2011).
74. NCT02449850. Preventing atopic dermatitis and allergies in children (PreventADALL). clinicaltrials.gov/ct2/show/NCT02449850 (first received 20 May 2015).
75. NCT03376243. EARLYEMOLLIENT - Feasibility of early emollient use in children with atopic eczema (EARLYemo). clinicaltrials.gov/ct2/show/NCT03376243 (first received 18 December 2017).
76. NICE. Postnatal care up to 8 weeks after birth. www.nice.org.uk/guidance/cg37 (accessed prior to 24 January 2019).
77. Oakley R, Lawton S. Views on unwanted effects of leave-on emollients and experiences surrounding their incidence. Dermatological Nursing 2016;15(4):38-43.
78. Osborne NJ, Koplin JJ, Martin PE, Gurrin LC, Lowe AJ, Matheson MC, et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. Journal of Allergy and Clinical Immunology 2011;127(3):668-76 e1-2.
79. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics 2006;38(4):441-6.
80. Pawankar R. Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organization Journal 2014;7(1):12.
81. Penzer R. Best practice in emollient therapy: a statement for healthcare professionals December 2012. Dermatological Nursing 2012;11(4):60-79.
82. Poulos LM, Waters A-M, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. Journal of Allergy and Clinical Immunology 2007;120(4):878-84.
83. Prescott SL, Pawankar R, Allen KJ, Campbell DE, Sinn JKh, Fiocchi A, et al. A global survey of changing patterns of food allergy burden in children. World Allergy Organization Journal 2013;6(1):21.
84. Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Dermatologic Therapy 2004;17(Suppl 1):49-56.
85. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
86. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. Journal of the European Academy of Dermatology and Venereology 2012;26(8):1045-60.
87. Rønnstad AT, Halling-Overgaard A-S, Hamann CR, Skov L, Egeberg A, Thyssen JP. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis. Journal of the American Academy of Dermatology 2018;79(3):448-56.e30.
88. Rucker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Statistics in Medicine 2008;27(5):746-63.
89. Sicherer SH, Muñoz-Furlong A, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. Journal of Allergy and Clinical Immunology 2003;112(6):1203-7.
90. Simpson EL, Keck LE, Chalmers JR, Williams HC. How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies. Journal of Allergy and Clinical Immunology 2012;130(1):137-44.
91. Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WHI, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. Journal of Allergy and Clinical Immunology 2014;134(4):818-23.
92. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. Journal of Allergy and Clinical Immunology 2003;112(6 Suppl):S118-27.
93. StataCorp. Stata. Version 15. College Station, TX, USA: StataCorp, 2017.
94. Stewart LA, Tierney JF, Clarke M. Chapter 18. Reviews of individual patient data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
95. Tierney JF, Stewart LA, Clarke M. Chapter 26, Individual patient data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
96. Stone KD. Atopic diseases of childhood. Current Opinion in Pediatrics 2002;145(5):634-46.
97. Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. European Journal of Immunology 2004;34(8):2100-9.
98. Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clinical and Experimental Allergy 2005;35(6):757-66.
99. Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Archives of Disease in Childhood 1997;76(2):159-62.
100. Surber C, Kottner J. Skin care products: what do they promise, what do they deliver. Journal of Tissue Viability 2017;26(1):29-36.
101. Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, James A, et al. Data sharing statements for clinical trials — a requirement of the International Committee of Medical Journal Editors. New England Journal of Medicine 2017;376(23):2277-9.
102. Thomsen SF. Epidemiology and natural history of atopic diseases. European Clinical Respiratory Journal 2015;2(1):24642.
103. Tsakok T, Marrs T, Mohsin M, Baron S, du Toit G, Till S, et al. Does atopic dermatitis cause food allergy? A systematic review. Journal of Allergy and Clinical Immunology 2016;137(4):1071-8.
104. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. Journal of Allergy and Clinical Immunology 2015;135(4):956-63.e1.
105. Umasunthar T, Leonardi-Bee J, Hodes M, Turner PJ, Gore C, Habibi P, et al. Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clinical and Experimental Allergy 2013;43(12):1333-41.
106. Van Cleave J, Gortmaker SL, Perrin JM. Dynamics of obesity and chronic health conditions among children and youth. JAMA 2010;303(7):623-30.
107. Van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009;339:b2433.
108. Van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen AP, Arents BW. Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews 2017, Issue 2. [DOI: 10.1002/14651858.CD012119.pub2]
109. Venter C, Pereira B, Voigt K, Grundy J, Clayton CB, Higgins B, et al. Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life. Allergy 2008;63(3):354-9.
110. Voskamp AL, Zubrinich CM, Abramovitch JB, Rolland JM, O’Hehir RE. Goat's cheese anaphylaxis after cutaneous sensitization by moisturizer that contained goat's milk. Journal of Allergy and Clinical Immunology 2014;2(5):629-30.
111. Weidinger S, Novak N. Atopic Dermatitis. Lancet 2016;387(10023):1109-22.
112. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75.
113. World Health Organization. Pregnancy, Childbirth, Postpartum and Newborn Care: A Guide for Essential Practice. www.ncbi.nlm.nih.gov/books/NBK326678/ (accessed prior to 11 March 2019).
114. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. British Journal of Dermatology 1994;131(3):383-96.
115. Williams HC, Strachan DP. The natural history of childhood eczema: observations from the British 1958 birth cohort study. British Journal of Dermatology 1998;139(5):834-9.
116. Woods RK, Stoney RM, Raven J, Walters EH, Abramson M, Thien FC. Reported adverse food reactions overestimate true food allergy in the community. European Journal Of Clinical Nutrition 2002;56(1):31-6.
117. Yosipovitch G, Maayan-Metzger A, Merlob P, Sirota L. Skin barrier properties in different body areas in neonates. Pediatrics 2000;106(1):105-8.